%, correspondingly. Such reduction in gross profit margin was caused by change in product mix, rise in production costs and increase in packaging cost purchased from external party. Gross profits margin from domestic
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
the Three-month and Six-month Periods Ended 30 June, 2019 Page 1 (Translation) 1. Significant events of the 2 nd quarter of 2019 1.1 Change of the Company’s name and seal On April 12, 2019, the 2019
million increased when comparing to Baht 509 million from the end of 2019 due to the change in classification from TFRS 9 for financial assets classified as Purchased or originated credit impaired from
increase in Ft rate. Q3/2018 Financial and Operating Highlights * ไม่รวมต้นทุนค่าเสื่อมราคาและค่าตัดจ าหน่าย Operating highlight in Q3/2018 Q3/17 Q2/18 Q3/18 Change +/(-) 9M/17 9M/18 Change +/(-) (THB
would like to clarify the change in operating results the year ended December 31, 2018 with details as follows: Unit : million baht Statement of financial position For the year ended 31 December 2018
been a change in the necessary circumstances as provided in the first paragraph, the Minister upon the recommendation of the SEC may modify or change the conditions already specified.
been a change in the necessary circumstances as provided in the first paragraph, the Minister upon the recommendation of the SEC may modify or change the conditions already specified.
Assistance (Addition) and Change of Company Director 28/10/2021 18:00 Interim omitted Dividend, Notification of Entering into a Connected Transaction Regarding the Receipt of Financial Assistance and Change of
Discussion & Analysis Q3/2022 Operating Highlights in Q3/2022 Q3/21 Q3/22 Change +/(-) 9M/21 9M/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 115 246 114% 431 674 56% Gross Profit 60 159 165% 242